SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026250
Filing Date
2018-11-01
Accepted
2018-11-01 16:21:55
Documents
56
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q omed-10q_20180930.htm 10-Q 1656162
2 EX-31.1 omed-ex311_6.htm EX-31.1 16501
3 EX-31.2 omed-ex312_8.htm EX-31.2 16519
4 EX-32.1 omed-ex321_9.htm EX-32.1 8643
  Complete submission text file 0001564590-18-026250.txt   6473385

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT omed-20180930.xml EX-101.INS 1650637
6 XBRL TAXONOMY EXTENSION SCHEMA omed-20180930.xsd EX-101.SCH 37285
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20180930_cal.xml EX-101.CAL 31625
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20180930_def.xml EX-101.DEF 155205
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20180930_lab.xml EX-101.LAB 273317
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20180930_pre.xml EX-101.PRE 249217
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 181154054
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1